CN1142370A - Capsule for cerebral arteriosclerosis - Google Patents
Capsule for cerebral arteriosclerosis Download PDFInfo
- Publication number
- CN1142370A CN1142370A CN95109311A CN95109311A CN1142370A CN 1142370 A CN1142370 A CN 1142370A CN 95109311 A CN95109311 A CN 95109311A CN 95109311 A CN95109311 A CN 95109311A CN 1142370 A CN1142370 A CN 1142370A
- Authority
- CN
- China
- Prior art keywords
- gram
- capsule
- radix
- medicine
- cerebral arteriosclerosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A casule for curing cerebral arteriosclerosis with the symptoms such as headache, dizziness, amnesia, acrognosis, tinvitus, deafness, insomnia and emotional dysphoria features obvious curative effect (more than 98% of effective rate), low cost and no by-effect.
Description
A kind of Chinese patent medicine and manufacture method thereof for the treatment of cerebral arteriosclerosis disease.
At present, known cerebral arteriosclerosis medicine " Radix Salviae Miltiorrhizae Tabellae ", " troxerutin ", " beniol ", " ZHENGTIAN WAN " of being used for the treatment of is to cold stasis of blood headache, and feeling of fullness in the head is effective; " positive brain peaceful " though the merit of YIN nourishing, supplementing the brain collateral dredging is arranged, little to deficiency of vital energy blood adstringency headache effect, analyze its reason, all owing to pathogenic factor and mechanism still indeterminate due to.
The present invention is according to tcm theory: cerebral arteriosclerosis be a kind of because of deficiency of QI in middle-JIAO, deficiency of both the liver and kidney, the cloudy two empty blood that form of gas are not smooth and hold under the arm on the expectorant and disturb, the disease of deficiency in origin and excess in superficiality, proposing as the pathogenesis development mainly is the new drug of approach treatment cerebral arteriosclerosis with the kidney invigorating, QI invigorating, clearing away liver-fire.This medicine manufacturing is simple, inexpensive, does not have the effect of paying, and effective percentage is to treat the ideal substitute products of cerebral arteriosclerosis medicine at present more than 98%.The present invention has had the function of two-ways regulation blood pressure from clinical confirmation, can fall, can rise hypertension hypotension, the amplitude of accommodation is generally ± 2.6-4KPa,, depression of liver-QI fidgety to emotion, dim eyesight, tinnitus patient act on obviously, effective to all kinds of headaches and systemic pain, and have the analgesia of dispeling the wind to alleviate the function of neck rigidity, hemorheology, optical fundus blood vessel inspection are obviously changed.
Capsule of the present invention with benefiting QI for activating blood circulation, nourishing YIN to lower pathogenic fire, liver and kidney tonifying, warming the spleen reduce phlegm, collateral dredging Fructus Alpiniae Oxyphyllae, qi and blood tonifying be purpose, with Radix Codonopsis, Rhizoma Gastrodiae, Radix Glycyrrhizae is principal agent, with Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Radix Puerariae blood circulation promoting and blood stasis dispelling, supports through collateral dredging, on reach mountain peak top, assign the sea of blood, promoting tissue regeneration by removing blood stasis; With Cortex Eucommiae liver and kidney tonifying, bone and muscle strengthening, the Fructus Alpiniae Oxyphyllae of Fructus Alpiniae Oxyphyllae the kidney warming, the Rhizoma Acori Graminei consciousness-restoring and orifice-opening reduces phlegm, and gas foot, QI and blood were transferred during all medicines share then, blood vessels are lived, all wind removes, and deficiency-heat is clear, has realized benefiting QI for activating blood circulation, and warming middle-JIAO is gone up clearly and is mended ground purpose down.
This capsular medicine forms and content range is:
Radix Codonopsis 20-30 gram Rhizoma Gastrodiae 10-20 gram
Fructus Alpiniae Oxyphyllae 10-20 gram Rhizoma Chuanxiong 10-20 gram
Radix Salviae Miltiorrhizae 30-50 gram radix curcumae 10-20 gram
Radix Bupleuri 10-20 gram Radix Puerariae 10-20 gram
Cortex Eucommiae 10-20 gram Folium Mori 10-20 gram
Concha Ostreae 20-30 gram Radix Glycyrrhizae 10-20 gram
Rhizoma Acori Graminei 10-20 gram
This capsular manufacture method is:
1, above various medicines to be asked for a rearmounted vessel that mix according to part by weight separately, add cold water and flood and decoct twice, each about two hours.
2, will decoct medicinal liquid after twice and mix after, leave standstill and extract pure clear liquid medicine after 24 hours, vacuum decompression is condensed into thick paste,
3, will concentrate thick paste and become thin foam with temperature oven dry back, 80 ℃ of left and right sides powder, the common capsule for medicine of uniform device forms.This capsule is through headache, dizzy, forgetful, numb limbs and tense tendons, deafness, clinical the taking of patient's thousand examples such as sleep is poor and emotion is fidgety, treatment front and back blood test situation such as following table:
Hemorheology index changes (mean value standard error)
| Whole blood viscosity | Plasma viscosity | Triglyceride | Cholesterol | Erythrocyte sedimentation rate | |
| Before the treatment | 2.75±0.19 | 1.21±0.04 | 0.9±2.6 | 3.4±8.8 | 25.1±3.55 |
| After the treatment | 1.64±0.17 | 1.03±0.05 | 0.3±0.9 | 2.2±4.3 | 16.34±1.57 |
From table, can find out with treatment bleeding from anus rheology index notable difference (P＜0.05) is arranged before the treatment
Claims (2)
1, a kind of capsule for the treatment of cerebral arteriosclerosis disease is characterized in that this capsule is made up of the medicine of following composition and corresponding weight range thereof:
Radix Codonopsis 20-30 gram Rhizoma Gastrodiae 10-20 gram
Fructus Alpiniae Oxyphyllae 10-20 gram Rhizoma Chuanxiong 10-20 gram
Radix Salviae Miltiorrhizae 30-50 gram radix curcumae 10-20 gram
Radix Bupleuri 10-20 gram Radix Puerariae 10-20 gram
Cortex Eucommiae 10-20 gram Folium Mori 10-20 gram
Concha Ostreae 20-30 gram Radix Glycyrrhizae 10-20 gram
Rhizoma Acori Graminei 10-20 gram
2, this capsular manufacture method is:
(1), above various medicines will be asked for a rearmounted vessel that mix according to part by weight separately, add water logging and do not decoct twice, each about two hours.
(2), the medicinal liquid that will decoct after twice mixes, and leaves standstill and extracts pure clear liquid medicine after 24 hours, vacuum decompression is condensed into thick paste.
(3), will concentrate thick paste and become thin foam with 80 ℃ of left and right sides temperature oven dry back powder, the common capsule for medicine of uniform device forms.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95109311A CN1059805C (en) | 1995-08-07 | 1995-08-07 | Capsule for cerebral arteriosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95109311A CN1059805C (en) | 1995-08-07 | 1995-08-07 | Capsule for cerebral arteriosclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1142370A true CN1142370A (en) | 1997-02-12 |
| CN1059805C CN1059805C (en) | 2000-12-27 |
Family
ID=5077125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95109311A Expired - Fee Related CN1059805C (en) | 1995-08-07 | 1995-08-07 | Capsule for cerebral arteriosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1059805C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435922A (en) * | 2014-12-19 | 2015-03-25 | 李建德 | Traditional Chinese medicine composition for treating arteriosclerosis |
| CN108434402A (en) * | 2018-05-16 | 2018-08-24 | 重庆跃龙生物制药有限公司 | Chinese medicine composition and preparation method thereof for treating artery sclerosis |
| CN115737778A (en) * | 2022-12-28 | 2023-03-07 | 李海霞 | Traditional Chinese medicine preparation with pressure regulating effect |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1058535A (en) * | 1990-07-27 | 1992-02-12 | 吴万臣 | Cerebral embolism ablation capsule |
| CN1053189A (en) * | 1990-12-25 | 1991-07-24 | 冯虎平 | The preparation method of " promoting blood circulation and restoring paralysis pills " |
| CN1073103A (en) * | 1992-12-11 | 1993-06-16 | 唐山市龙山制药厂 | Prescription of Xueshuankang capsule and its preparation technology |
| CN1081897A (en) * | 1993-04-24 | 1994-02-16 | 王筱溥 | Musk naotongsu |
-
1995
- 1995-08-07 CN CN95109311A patent/CN1059805C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435922A (en) * | 2014-12-19 | 2015-03-25 | 李建德 | Traditional Chinese medicine composition for treating arteriosclerosis |
| CN108434402A (en) * | 2018-05-16 | 2018-08-24 | 重庆跃龙生物制药有限公司 | Chinese medicine composition and preparation method thereof for treating artery sclerosis |
| CN115737778A (en) * | 2022-12-28 | 2023-03-07 | 李海霞 | Traditional Chinese medicine preparation with pressure regulating effect |
| CN115737778B (en) * | 2022-12-28 | 2023-10-27 | 李海霞 | Traditional Chinese medicine preparation with pressure regulating effect |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1059805C (en) | 2000-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1317027C (en) | Chinese medicine for treating depression | |
| CN101732486A (en) | Health-preserving wine | |
| CN1079253C (en) | Medicinal oil for dredging channels and collaterals of heart and brain and its preparing process | |
| CN103356944B (en) | A kind of Chinese medicine composition for the treatment of anemia | |
| CN1150046A (en) | Health medicinal liquor and preparing process thereof | |
| CN1059805C (en) | Capsule for cerebral arteriosclerosis | |
| CN103623385B (en) | A kind of Chinese medicine for the treatment of oral ulcer | |
| CN1228993A (en) | Traditional Chinese medicine for treating tuberculosis | |
| CN100387283C (en) | Chinese traditional medicine for treating diabetes retinopathy | |
| CN111000969A (en) | Pharmaceutical composition for treating simple obesity and preparation method thereof | |
| CN101352508B (en) | Chinese medicine for treating infertility and preparation method thereof | |
| CN101683464A (en) | Chinese medicinal composition for tonifying kidney and promoting blood circulation | |
| CN110859908A (en) | Traditional Chinese medicine composition for tonifying kidney and strengthening heart | |
| CN104324243A (en) | Traditional Chinese medicine preparation for treating female menopause insomnia | |
| CN102641443B (en) | Chinese medicament for treating dizziness | |
| CN102451439A (en) | Chinese medicinal formula for treating Meniere's syndrome | |
| CN1056242A (en) | Consolidate the compound method of near-sighted refinery liquor | |
| CN102423367B (en) | Beautifying and blood-activating medicament | |
| CN105213849A (en) | A kind of Chinese medicine for the treatment of renal failure | |
| CN105267884A (en) | Medicine for mitral valve combined aortic lesion heart disease | |
| CN104306943A (en) | Traditional Chinese medicine combination for curing hyperlipidemia | |
| CN104306744A (en) | Foot bath composition for treating neurasthenia | |
| CN104043083A (en) | Traditional Chinese medicine composition for treating woman metrorrhagia and metrostaxis | |
| CN103463419A (en) | Preparation method of ointment used for peripheral nerve injury postoperative repair | |
| CN117482175A (en) | Traditional Chinese medicine composition for treating diabetic nephropathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |